LSO AGM & Breakfast Series
MarchMar 17 2022 09:00am - 10:00pm
Trends and Areas to Watch in Life Science Sector
Guest Speaker: Brian Bloom, Co-founder, Chairman and Chief Executive Officer, Bloom Burton & Co
Brian Bloom is a co-founder of Bloom Burton & Co. and serves as the firm’s Chairman and Chief Executive Officer. By forging unique relationships with international healthcare-specialized investors, Brian raises capital for Canadian healthcare companies while helping investors realize returns.
Brian serves on the Board of Directors of Triumvira Immunologics, Appili Therapeutics, Satellos Bioscience and Qing Bile Therapeutics. Brian was formerly the Chairman of the Board of Grey Wolf Animal Health, a member of the Life Sciences Advisory Board at the National Research Council of Canada, the Dean’s Advisory Board at McMaster University and on the Board of Directors of BIOTECanada and the Baycrest Foundation.
Before co-founding Bloom Burton in 2008, Brian spent six years at Dundee Securities in the healthcare and biotechnology institutional sales and equity research groups. Brian started his career at New York-based investment banking firms SCO Financial Group and Molecular Securities. Brian received an Honors Bachelor of Science in Biochemistry from McMaster University and subsequently studied at the Mount Sinai Graduate School for Biological Sciences of New York University, with a focus in molecular endocrinology and biophysics. Brian is the proud recipient of the McMaster University 2017 Distinguished Alumni Award in Science.
LSO - NOTICE OF ANNUAL GENERAL MEETING
Notice is hereby given that the annual meeting (the “Meeting”) of the members of LSO (the "Corporation") will be held in a virtual only meeting format due to the public health concerns caused by the COVID-19 pandemic. The Meeting will take place via live webcast online which members may access through a link that will be sent to each member who registers (Click here)
The Meeting will be held on Thursday, the 17th day of March, 2022 at 9:00 a.m. (Eastern) for the following purposes to:
- elect directors;
- appoint auditors;
- receive the financial statements for the fiscal year ended December 31, 2021;
- receive the Chair’s report; and
- transact such other business as may properly come before the meeting.
Event is in progress